鐿鈦

-0.50 (-0.39%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

128.5049成交張數21.82本益比2.41股價淨值比2.72%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	48	27	42.0%	1.90	53.35	11.4%	6.3%	1.3	1.2
2026Q1	48	26	44.6%	1.82	51.52	9.0%	4.9%	1.3	1.2
2025Q4	48	27	42.9%	2.13	54.53	9.4%	5.2%	1.1	0.8
2025Q3	48	26	44.2%	2.08	52.60	9.4%	5.1%	1.5	1.3
2025Q2	47	25	45.3%	2.25	50.67	8.4%	4.4%	0.7	0.6
2025Q1	47	25	44.9%	2.39	50.93	10.0%	5.4%	1.3	1.1
2024Q4	47	26	42.8%	2.84	52.47	10.2%	5.5%	0.3	0.0
2024Q3	47	25	44.4%	3.07	51.10	8.3%	4.3%	1.1	0.9
2024Q2	47	25	46.2%	2.98	49.99	11.1%	5.6%	1.3	1.1
2024Q1	48	26	44.8%	3.67	51.80	12.3%	6.5%	0.1	-0.1
2023Q4	48	25	47.1%	3.31	49.59	14.4%	7.3%	2.2	1.3
2023Q3	48	25	47.5%	3.43	50.77	16.3%	8.2%	1.5	1.4
2023Q2	48	23	49.8%	1.98	48.43	21.3%	10.4%	0.4	0.2
2023Q1	46	24	48.0%	1.98	49.16	21.0%	10.8%	1.7	0.4
2022Q4	46	23	50.5%	1.81	46.68	20.2%	10.2%	2.0	1.0
2022Q3	44	22	49.9%	1.87	45.50	21.7%	11.0%	1.6	0.8
2022Q2	41	20	51.2%	2.30	41.35	16.5%	8.5%	0.5	-0.4
2022Q1	39	20	48.5%	2.39	41.72	13.7%	7.2%	0.1	-0.4
2021Q4	37	19	48.4%	2.26	39.89	12.1%	6.3%	0.0	-1.1
2021Q3	36	19	47.9%	2.29	38.55	10.3%	5.6%	0.1	-0.5
2021Q2	36	20	44.9%	2.54	40.53	9.2%	5.1%	0.5	-0.3
2021Q1	35	19	45.2%	2.46	39.79	10.8%	6.2%	-0.1	-0.3
2020Q4	35	19	46.2%	2.37	38.50	13.4%	7.6%	1.0	0.4
2020Q3	33	18	43.4%	2.51	38.25	14.1%	8.2%	0.9	0.8
2020Q2	32	18	43.7%	2.50	44.57	16.9%	8.9%	-0.0	-0.4
2020Q1	32	19	38.8%	3.33	47.78	20.2%	11.4%	1.2	0.9
2019Q4	30	18	39.2%	3.40	45.71	21.0%	12.0%	1.4	1.3
2019Q3	30	18	39.3%	3.47	44.61	23.6%	13.3%	0.4	0.4
2019Q2	34	17	50.2%	2.06	42.22	23.8%	11.9%	2.5	2.4
2019Q1	33	17	47.6%	2.29	42.53	21.2%	11.0%	0.6	0.4
2018Q4	30	16	46.5%	2.32	40.54	19.0%	10.0%	0.8	0.6
2018Q3	30	16	47.8%	2.25	38.75	17.0%	8.7%	1.2	1.0
2018Q2	30	15	50.2%	1.35	36.81	16.2%	7.9%	0.7	0.3
2018Q1	28	15	48.5%	1.40	36.43	11.2%	6.0%	0.9	0.7
2017Q4	28	14	49.1%	1.39	35.61	10.2%	5.4%	1.3	1.2
2017Q3	28	14	50.1%	1.35	34.93	14.0%	7.2%	-0.2	-0.2
2017Q2	28	13	52.1%	1.99	33.55	15.4%	7.9%	0.4	0.3
2017Q1	27	15	43.6%	2.73	38.47	19.6%	11.5%	0.5	0.5
2016Q4	28	15	45.7%	2.47	38.16	–	–	0.9	0.9
2016Q3	27	15	46.5%	2.33	36.29	–	–	1.2	1.2